These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 27423379)
1. The influence of age and other prognostic factors associated with survival of ovarian immature teratoma - A study of 1307 patients. Chan JK; Gardner AB; Chan JE; Guan A; Alshak M; Kapp DS Gynecol Oncol; 2016 Sep; 142(3):446-51. PubMed ID: 27423379 [TBL] [Abstract][Full Text] [Related]
2. Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States. Fuh KC; Shin JY; Kapp DS; Brooks RA; Ueda S; Urban RR; Chen LM; Chan JK Gynecol Oncol; 2015 Mar; 136(3):491-7. PubMed ID: 25455734 [TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for pure ovarian immature teratoma and the role of adjuvant chemotherapy in stage I diseases. Li S; Zhang X; Zhang T; Yin M; Cao D; Xiang Y; Yang J Ann Med; 2023; 55(2):2273984. PubMed ID: 37909181 [TBL] [Abstract][Full Text] [Related]
4. Relationship status and other demographic influences on survival in patients with ovarian cancer. Gardner AB; Sanders BE; Mann AK; Liao CI; Eskander RN; Kapp DS; Chan JK Int J Gynecol Cancer; 2020 Dec; 30(12):1922-1927. PubMed ID: 32920535 [TBL] [Abstract][Full Text] [Related]
5. The demographic features, clinicopathologic characteristics, treatment outcome and disease-specific prognostic factors of solitary fibrous tumor: a population-based analysis. Wushou A; Jiang YZ; Liu YR; Shao ZM Oncotarget; 2015 Dec; 6(39):41875-83. PubMed ID: 26496033 [TBL] [Abstract][Full Text] [Related]
6. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery. Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695 [TBL] [Abstract][Full Text] [Related]
7. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Kapp DS; Shin JY; Chan JK Cancer; 2008 Feb; 112(4):820-30. PubMed ID: 18189292 [TBL] [Abstract][Full Text] [Related]
10. Racial disparities in survival among patients with germ cell tumors of the ovary--United States. Bryant CS; Kumar S; Shah JP; Mahdi H; Ali-Fehmi R; Munkarah AR; Deppe G; Morris RT Gynecol Oncol; 2009 Sep; 114(3):437-41. PubMed ID: 19560191 [TBL] [Abstract][Full Text] [Related]
11. Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States. Chan JK; Zhang M; Hu JM; Shin JY; Osann K; Kapp DS J Surg Oncol; 2008 Feb; 97(2):103-7. PubMed ID: 17979133 [TBL] [Abstract][Full Text] [Related]
12. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis. Wang J; Li J; Chen R; Lu X Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285 [TBL] [Abstract][Full Text] [Related]
13. Mature and immature teratoma: A report from the second Italian pediatric study. Terenziani M; D'Angelo P; Inserra A; Boldrini R; Bisogno G; Babbo GL; Conte M; Dall' Igna P; De Pasquale MD; Indolfi P; Piva L; Riccipetitoni G; Siracusa F; Spreafico F; Tamaro P; Cecchetto G Pediatr Blood Cancer; 2015 Jul; 62(7):1202-8. PubMed ID: 25631333 [TBL] [Abstract][Full Text] [Related]
14. Head & neck acinar cell carcinoma: a population-based study using the seer registry. Yibulayin F; Feng L; Wang M; Lu MM; Luo Y; Liu H; Yang ZC; Wushou A BMC Cancer; 2020 Jul; 20(1):631. PubMed ID: 32641007 [TBL] [Abstract][Full Text] [Related]
15. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes. Gardner AB; Charo LM; Mann AK; Kapp DS; Eskander RN; Chan JK Clin Exp Metastasis; 2020 Feb; 37(1):107-113. PubMed ID: 31758289 [TBL] [Abstract][Full Text] [Related]
16. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines. Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors and Survival Outcome in Patients with Chordoma in the United States: A Population-Based Analysis. Lee IJ; Lee RJ; Fahim DK World Neurosurg; 2017 Aug; 104():346-355. PubMed ID: 28457925 [TBL] [Abstract][Full Text] [Related]
18. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis. Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642 [TBL] [Abstract][Full Text] [Related]
19. Characteristics, treatment and outcomes of women with immature ovarian teratoma, 1998-2012. Jorge S; Jones NL; Chen L; Hou JY; Tergas AI; Burke WM; Ananth CV; Neugut AI; Herhshman DL; Wright JD Gynecol Oncol; 2016 Aug; 142(2):261-6. PubMed ID: 27222024 [TBL] [Abstract][Full Text] [Related]